Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment.
about
Theiler's virus infection: a model for multiple sclerosisThe use of magnetic resonance imaging in multiple sclerosis: lessons learned from clinical trials.P-glycoprotein acts as an immunomodulator during neuroinflammation.Short-term stability of T1 and T2 relaxation measures in multiple sclerosis normal appearing white matter.Diseases of white matter and schizophrenia-like psychosis.The pathology of primary progressive multiple sclerosis.Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift.Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damageA rational design approach for developing immunomodulators based on CD4 and CD8.Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies.Pathologic classification systems in MS: what is their significance?Glatiramer acetate in multiple sclerosis.The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion.PPAR Regulation of Inflammatory Signaling in CNS Diseases.Mechanisms of primary axonal damage in a viral model of multiple sclerosis.Magnetic resonance diffusion tensor imaging for occult lesion detection in multiple sclerosisPolarization of macrophages and microglia in inflammatory demyelination.Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 - 2014).Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases.Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex.Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy.Astrocyte-derived retinoic acid: a novel regulator of blood-brain barrier function in multiple sclerosis.The complement system as a biomarker of disease activity and response to treatment in multiple sclerosis.Alterations in neuronal gene expression profiles in response to experimental demyelination and axonal transection.Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.
P2860
Q24629115-99B7166D-7387-4ED7-BA37-47A7A91F49BEQ30953733-3F4187E8-4FFD-475E-9D2A-999E39C4BA18Q30973736-6DEF255D-1767-4EAD-B445-C23C7BB2ECB4Q34084263-6AAA1029-EE46-45EC-AF66-FF29C3E3A0F3Q34451609-41668811-3B58-4977-9A2B-D9FC7572EFAEQ34625041-0C314A00-09A3-4C4A-9BCF-6B6A1DB75C3FQ34956279-4C2B62A2-4E37-4AD2-8A99-EE076B204E00Q35028421-D3D785D7-5BCB-4AF4-AD0F-0DC4E558D234Q35042491-0BE72F50-32EC-4A1B-8FEA-C2175D3131A6Q35094706-7EC8EE1F-1F37-4A6F-B27B-7980CC9587ABQ36054808-4E07EF63-3A36-481E-9764-1F02AE07CEE6Q36198583-1132F29C-A92F-44E2-89BB-28131357CFA7Q36455702-47441E7B-6658-4040-AC6F-C92D379482D3Q37231755-A30A6533-23BC-46CE-8775-6ED43791ECB5Q37355344-47B0DD88-A323-4E35-91B9-67D05C42370AQ37593993-D9303438-ACC4-4772-9B2C-8ABE5540DDA8Q38096246-3AF924B2-D6DC-486B-B8AC-051EEDC2A026Q38468023-0794D036-BED1-4129-8FE1-7E63B30EB312Q38728679-AD8E307B-0452-40DE-A203-0A6FCB928AE9Q39009182-2A87BBA8-BEDD-4436-8F5C-846D34737312Q39257867-D486BEC0-A529-4197-83C4-83C41CA39D69Q43089391-893B7709-5CF4-4A64-B963-8E012B164C74Q43957760-F660558F-7F8A-461E-A4B5-66E7963D2C52Q44685789-6FD10556-D5C6-425D-A7EC-34779129B8BAQ46848816-F556192C-8649-4BB3-BBC0-B3AE1E9C89DEQ47715259-7E0B60D8-D2F4-4092-A21C-506BCC77D11BQ48340172-A209DDE9-C3A4-4B2F-AA3D-B18F1278351FQ51648083-C55ED0FF-2060-435E-9A88-27441B33142E
P2860
Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Multiple sclerosis: recent dev ...... imaging studies and treatment.
@ast
Multiple sclerosis: recent dev ...... imaging studies and treatment.
@en
type
label
Multiple sclerosis: recent dev ...... imaging studies and treatment.
@ast
Multiple sclerosis: recent dev ...... imaging studies and treatment.
@en
prefLabel
Multiple sclerosis: recent dev ...... imaging studies and treatment.
@ast
Multiple sclerosis: recent dev ...... imaging studies and treatment.
@en
P2093
P1476
Multiple sclerosis: recent dev ...... imaging studies and treatment.
@en
P2093
Lucchinetti C
Noseworthy J
P304
P356
10.1097/00019052-200106000-00002
P577
2001-06-01T00:00:00Z